Have a feature idea you'd love to see implemented?
Let us know!
TMCI Treace Medical Concepts Inc
Price (delayed)
$7.94
Market cap
$494.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.99
Enterprise value
$552.25M
Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The
Highlights
TMCI's revenue is up by 16% YoY and by 2.2% QoQ
Treace Medical Concepts's gross profit has increased by 15% YoY and by 2.1% from the previous quarter
Treace Medical Concepts's quick ratio has decreased by 37% YoY but it has increased by 3.3% QoQ
The company's net income fell by 29% YoY but it rose by 3.4% QoQ
The equity has declined by 24% year-on-year and by 6% since the previous quarter
Key stats
What are the main financial stats of TMCI
Market
Valuations
Earnings
Shares outstanding
62.3M
Market cap
$494.64M
Enterprise value
$552.25M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.71
Price to sales (P/S)
2.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.72
Revenue
$202.86M
EBIT
-$56.28M
EBITDA
-$47.13M
Free cash flow
-$43.2M
Per share
Balance sheet
Liquidity
EPS
-$0.99
Free cash flow per share
-$0.69
Book value per share
$1.69
Revenue per share
$3.26
TBVPS
$3.08
Total assets
$212.92M
Total liabilities
$108.02M
Debt
$69.72M
Equity
$104.91M
Working capital
$119.34M
Debt to equity
0.66
Current ratio
4.12
Quick ratio
2.8
Net debt/EBITDA
-1.22
Margins
Efficiency
Dividend
EBITDA margin
-23.2%
Gross margin
80.6%
Net margin
-30.3%
Operating margin
-30.7%
Return on assets
-26.4%
Return on equity
-51.1%
Return on invested capital
-25.1%
Return on capital employed
-32.2%
Return on sales
-27.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TMCI stock price
How has the Treace Medical Concepts stock price performed over time
Intraday
-0.5%
1 week
4.06%
1 month
48.13%
1 year
-6.59%
YTD
-37.73%
QTD
36.9%
Financial performance
How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$202.86M
Gross profit
$163.53M
Operating income
-$62.27M
Net income
-$61.52M
Gross margin
80.6%
Net margin
-30.3%
The company's net income fell by 29% YoY but it rose by 3.4% QoQ
The operating income has contracted by 29% YoY but it has grown by 4.1% from the previous quarter
TMCI's revenue is up by 16% YoY and by 2.2% QoQ
Treace Medical Concepts's gross profit has increased by 15% YoY and by 2.1% from the previous quarter
Growth
What is Treace Medical Concepts's growth rate over time
Valuation
What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
4.71
P/S
2.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.72
The EPS has declined by 27% year-on-year but it is up by 2.9% since the previous quarter
The equity has declined by 24% year-on-year and by 6% since the previous quarter
The P/S is 19% below the last 4 quarters average of 3.0
TMCI's revenue is up by 16% YoY and by 2.2% QoQ
Efficiency
How efficient is Treace Medical Concepts business performance
Treace Medical Concepts's return on invested capital has decreased by 39% YoY
The return on equity has declined by 36% year-on-year and by 3.2% since the previous quarter
Treace Medical Concepts's ROA has decreased by 25% YoY
The return on sales has declined by 14% year-on-year but it is up by 6% since the previous quarter
Dividends
What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TMCI.
Financial health
How did Treace Medical Concepts financials performed over time
TMCI's total assets is 97% greater than its total liabilities
Treace Medical Concepts's quick ratio has decreased by 37% YoY but it has increased by 3.3% QoQ
Treace Medical Concepts's current ratio has decreased by 27% YoY but it has increased by 7% from the previous quarter
TMCI's debt is 34% lower than its equity
The debt to equity has grown by 32% YoY and by 6% from the previous quarter
The equity has declined by 24% year-on-year and by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.